Compass Therapeutics Inc (CMPX)

11:34 AM

Strong Analyst Confidence in Compass Therapeutics (CMPX) Driven by CTX-10726 Advancement - MSN

11:34 AM

Apr 05, 2026

Portfolio Recap: Why is Compass Therapeutics Inc stock going downQuarterly Investment Review & Low Risk Growth Stock Ideas - baoquankhu1.vn

Apr 05, 2026

Apr 04, 2026

CMPX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 04, 2026

Apr 02, 2026

Compass Therapeutics Inc. (CMPX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Apr 02, 2026

Apr 02, 2026

CMPX Forecast, Price Target & Analyst Ratings | COMPASS THERAPEUTICS INC (NASDAQ:CMPX) - ChartMill

Apr 02, 2026

Apr 01, 2026

Analysts Offer Insights on Healthcare Companies: Lexeo Therapeutics, Inc. (LXEO), Bicara Therapeutics Inc. (BCAX) and Compass Therapeutics (CMPX) - The Globe and Mail

Apr 01, 2026

Mar 31, 2026

Traders Buy High Volume of Compass Therapeutics Call Options (NASDAQ:CMPX) - marketbeat.com

Mar 31, 2026

Mar 31, 2026

Stifel reiterates Compass Therapeutics stock rating ahead of trial data By Investing.com - Investing.com Canada

Mar 31, 2026

Mar 31, 2026

Stifel reiterates Compass Therapeutics stock rating ahead of trial data - Investing.com

Mar 31, 2026

Mar 31, 2026

Stifel Maintains Compass Therapeutics(CMPX.US) With Buy Rating, Maintains Target Price $12 - Moomoo

Mar 31, 2026

Mar 31, 2026

CMPX Stock Price, Quote & Chart | COMPASS THERAPEUTICS INC (NASDAQ:CMPX) - ChartMill

Mar 31, 2026

Mar 28, 2026

Fundamentals Check: Why is Compass Therapeutics Inc stock going downTrade Risk Summary & Consistent Profit Trading Strategies - baoquankhu1.vn

Mar 28, 2026

Mar 27, 2026

CMPX Technical Analysis | Trend, Signals & Chart Patterns | COMPASS THERAPEUTICS INC (NASDAQ:CMPX) - ChartMill

Mar 27, 2026

Mar 25, 2026

Compass Therapeutics (CMPX) Receives a Buy from Guggenheim - The Globe and Mail

Mar 25, 2026

Mar 25, 2026

Compass Therapeutics (NASDAQ:CMPX) Given “Buy” Rating at Guggenheim - Defense World

Mar 25, 2026

Mar 24, 2026

Compass Therapeutics (NASDAQ:CMPX) Receives Buy Rating from Guggenheim - MarketBeat

Mar 24, 2026

Mar 19, 2026

Compass Therapeutics: Potential Here, But Patience Required (NASDAQ:CMPX) - Seeking Alpha

Mar 19, 2026

Mar 18, 2026

Compass Therapeutics, Inc. (NASDAQ:CMPX) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Mar 18, 2026

Mar 17, 2026

Will Compass Therapeutics Inc stock go up in YEARWeekly Trade Summary & Fast Moving Market Watchlists - baoquankhu1.vn

Mar 17, 2026

Mar 17, 2026

Compass Therapeutics, Inc.Common Stock (NQ: CMPX - The Chronicle-Journal

Mar 17, 2026

Mar 16, 2026

Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing - AOL.com

Mar 16, 2026

Mar 15, 2026

Here's why Compass Therapeutics, Inc. (CMPX) is a great momentum stock to buy - MSN

Mar 15, 2026

Mar 14, 2026

Compass Therapeutics Sees Major Institutional Investment Boost - National Today

Mar 14, 2026

Mar 14, 2026

Compass Therapeutics, Inc. $CMPX Stock Position Lifted by Suvretta Capital Management LLC - MarketBeat

Mar 14, 2026

Mar 13, 2026

Cantor Fitzgerald Maintains Overweight on CMPX (Compass Therapeutics, Inc.), Mar 2026 - Meyka

Mar 13, 2026

Mar 13, 2026

Is Compass Therapeutics' (CMPX) New ESOP Shelf Offering Reframing Its Equity-Funded R&D Strategy? - simplywall.st

Mar 13, 2026

Mar 11, 2026

Compass Therapeutics Inc celebrates women leadership driving innovation in science and therapy development - Traders Union

Mar 11, 2026

Mar 09, 2026

Compass Therapeutics stock rating reaffirmed at Citizens on trial progress By Investing.com - Investing.com Canada

Mar 09, 2026

Mar 09, 2026

What Compass Therapeutics (CMPX)'s Pipeline Progress And 2025 Losses Reveal About Its Oncology Strategy - Yahoo Finance

Mar 09, 2026

Mar 09, 2026

HC Wainwright Has Positive Estimate for CMPX FY2026 Earnings - MarketBeat

Mar 09, 2026

Mar 07, 2026

Analysts Have Conflicting Sentiments on These Healthcare Companies: Silence Therapeutics (SLN), RxSight (RXST) and Compass Therapeutics (CMPX) - The Globe and Mail

Mar 07, 2026

Mar 06, 2026

What is HC Wainwright's Estimate for CMPX Q1 Earnings? - MarketBeat

Mar 06, 2026

Mar 06, 2026

Compass Therapeutics Reports 2025 Financial Results and Provides Corporate Update - Sahm

Mar 06, 2026

Mar 05, 2026

Jefferies raises Compass Therapeutics stock price target on trial progress By Investing.com - Investing.com Australia

Mar 05, 2026

Mar 05, 2026

Jefferies raises Compass Therapeutics stock price target on trial progress - Investing.com

Mar 05, 2026

Mar 05, 2026

Compass Therapeutics stock holds Outperform at William Blair ahead of trial data - Investing.com Canada

Mar 05, 2026

Mar 05, 2026

Raymond James reiterates Compass Therapeutics stock Outperform rating By Investing.com - Investing.com Canada

Mar 05, 2026

Mar 05, 2026

Raymond James reiterates Compass Therapeutics stock Outperform rating - Investing.com

Mar 05, 2026

Mar 05, 2026

Compass Therapeutics (NASDAQ:CMPX) Releases Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat

Mar 05, 2026

Mar 05, 2026

Compass Therapeutics Inc. reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 05, 2026

Mar 05, 2026

Compass Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com

Mar 05, 2026

Mar 05, 2026

Compass Therapeutics' Q4 Net Loss Narrows - marketscreener.com

Mar 05, 2026

Mar 05, 2026

Earnings Flash (CMPX) Compass Therapeutics Posts Q4 Net Loss $0.09 a Share, vs. FactSet Est of $0.09 Loss - marketscreener.com

Mar 05, 2026

Mar 05, 2026

Compass Therapeutics' 2025 net loss widens as R&D costs jump - TradingView

Mar 05, 2026

Mar 05, 2026

Compass Therapeutics 10-K: $0.0M Revenue, $(0.42) EPS on $(66.5)M Net Loss - TradingView

Mar 05, 2026

Mar 03, 2026

How Palo Alto’s New Stake and Rising Institutional Ownership At Compass Therapeutics (CMPX) Has Changed Its Investment Story - simplywall.st

Mar 03, 2026

Mar 03, 2026

Assessing Compass Therapeutics (CMPX) Valuation As CTX-009 Gains Attention In Biliary Tract Cancer Market - Yahoo Finance

Mar 03, 2026

Mar 03, 2026

Monashee Investment Management Boosts Stake in Compass Therapeutics - National Today

Mar 03, 2026